{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T05:26:08Z","timestamp":1773293168922,"version":"3.50.1"},"reference-count":47,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,2,1]],"date-time":"2015-02-01T00:00:00Z","timestamp":1422748800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001665","name":"Agence Nationale de la Recherche","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001665","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Acta Biomaterialia"],"published-print":{"date-parts":[[2015,2]]},"DOI":"10.1016\/j.actbio.2014.10.042","type":"journal-article","created":{"date-parts":[[2014,11,20]],"date-time":"2014-11-20T18:29:11Z","timestamp":1416508151000},"page":"150-158","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":34,"special_numbering":"C","title":["Inhibition of osteolysis and increase of bone formation after local administration of siRNA-targeting RANK in a polyethylene particle-induced osteolysis model"],"prefix":"10.1016","volume":"13","author":[{"given":"L.A.","family":"C\u00f3rdova","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V.","family":"Trichet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V.","family":"Escriou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Rosset","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Amiaud","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Battaglia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Charrier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Berreur","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Brion","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Gouin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Layrolle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.","family":"Passuti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Heymann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.actbio.2014.10.042_b0005","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1016\/j.biomaterials.2004.04.035","article-title":"The role of macrophages in osteolysis of total joint replacement","volume":"26","author":"Ingham","year":"2005","journal-title":"Biomaterials"},{"key":"10.1016\/j.actbio.2014.10.042_b0010","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.smim.2009.06.005","article-title":"Toll-like receptors (TLRs) and Nod-like receptors (NLRs) in inflammatory disorders","volume":"21","author":"Fukata","year":"2009","journal-title":"Semin Immunol"},{"key":"10.1016\/j.actbio.2014.10.042_b0015","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1002\/jor.20826","article-title":"Soluble and particulate Co-Cr-Mo alloy implant metals activate the inflammasome danger signaling pathway in human macrophages: a novel mechanism for implant debris reactivity","volume":"27","author":"Caicedo","year":"2009","journal-title":"J Orthop Res Off Publ Orthop Res Soc"},{"key":"10.1016\/j.actbio.2014.10.042_b0020","doi-asserted-by":"crossref","first-page":"5535","DOI":"10.1016\/j.biomaterials.2011.04.046","article-title":"Role of the Toll-like receptor pathway in the recognition of orthopedic implant wear-debris particles","volume":"32","author":"Pearl","year":"2011","journal-title":"Biomaterials"},{"key":"10.1016\/j.actbio.2014.10.042_b0025","doi-asserted-by":"crossref","first-page":"5044","DOI":"10.1016\/j.biomaterials.2007.06.035","article-title":"Wear particles, periprosthetic osteolysis and the immune system","volume":"28","author":"Goodman","year":"2007","journal-title":"Biomaterials"},{"key":"10.1016\/j.actbio.2014.10.042_b0030","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1002\/jor.21149","article-title":"Periprosthetic osteolysis: characterizing the innate immune response to titanium wear-particles","volume":"28","author":"Pierre","year":"2010","journal-title":"J Orthop Res"},{"key":"10.1016\/j.actbio.2014.10.042_b0035","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/jor.22190","article-title":"Orthopedic wear debris mediated inflammatory osteolysis is mediated in part by NALP3 inflammasome activation","volume":"31","author":"Burton","year":"2013","journal-title":"J Orthop Res Off Publ Orthop Res Soc"},{"key":"10.1016\/j.actbio.2014.10.042_b0040","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1007\/s11420-006-9003-6","article-title":"The central role of wear debris in periprosthetic osteolysis","volume":"2","author":"Purdue","year":"2006","journal-title":"HSS J Musculoskelet J Hosp Spec Surg"},{"key":"10.1016\/j.actbio.2014.10.042_b0045","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.actbio.2013.09.034","article-title":"Chronic inflammation in biomaterial-induced periprosthetic osteolysis: NF-\u03baB as a therapeutic target","volume":"10","author":"Lin","year":"2014","journal-title":"Acta Biomater"},{"key":"10.1016\/j.actbio.2014.10.042_b0050","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1359\/jbmr.071207","article-title":"Long-term protective effects of zoledronic acid on cancellous and cortical bone in the ovariectomized rat","volume":"23","author":"Gasser","year":"2008","journal-title":"J Bone Miner Res Off J Am Soc Bone Miner Res"},{"key":"10.1016\/j.actbio.2014.10.042_b0055","doi-asserted-by":"crossref","first-page":"R185","DOI":"10.1186\/ar2877","article-title":"A combination of methotrexate and zoledronic acid prevents bone erosions and systemic bone mass loss in collagen induced arthritis","volume":"11","author":"Le Goff","year":"2009","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.actbio.2014.10.042_b0060","doi-asserted-by":"crossref","first-page":"7610","DOI":"10.1158\/0008-5472.CAN-09-4272","article-title":"Zoledronic acid as a new adjuvant therapeutic strategy for Ewing\u2019s sarcoma patients","volume":"70","author":"Odri","year":"2010","journal-title":"Cancer Res"},{"key":"10.1016\/j.actbio.2014.10.042_b0065","doi-asserted-by":"crossref","first-page":"2981","DOI":"10.2174\/138161210793563554","article-title":"Therapeutic approach of primary bone tumours by bisphosphonates","volume":"16","author":"Moriceau","year":"2010","journal-title":"Curr Pharm Des"},{"key":"10.1016\/j.actbio.2014.10.042_b0070","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1038\/nrd3705","article-title":"Bench to bedside: elucidation of the OPG-RANK-RANKL pathway and the development of denosumab","volume":"11","author":"Lacey","year":"2012","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.actbio.2014.10.042_b0075","doi-asserted-by":"crossref","first-page":"2239","DOI":"10.1002\/jbmr.119","article-title":"Efficacy and safety of a once-yearly i.v. Infusion of zoledronic acid 5 mg versus a once-weekly 70-mg oral alendronate in the treatment of male osteoporosis: a randomized, multicenter, double-blind, active-controlled study","volume":"25","author":"Orwoll","year":"2010","journal-title":"J Bone Miner Res Off J Am Soc Bone Miner Res"},{"key":"10.1016\/j.actbio.2014.10.042_b0080","first-page":"jc20134440","article-title":"Two years of denosumab and teriparatide administration in postmenopausal women with osteoporosis (the DATA Extension Study): a randomized controlled trial","author":"Leder","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.actbio.2014.10.042_b0085","first-page":"n\/a","article-title":"Novel RANK antagonists for the treatment of bone resorptive disease: theoretical predictions and experimental validation","author":"T\u00e9letch\u00e9a","year":"2014","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.actbio.2014.10.042_b0090","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1359\/jbmr.2002.17.2.192","article-title":"In vivo RANK signaling blockade using the receptor activator of NF-kappaB:Fc effectively prevents and ameliorates wear debris-induced osteolysis via osteoclast depletion without inhibiting osteogenesis","volume":"17","author":"Childs","year":"2002","journal-title":"J Bone Miner Res Off J Am Soc Bone Miner Res"},{"key":"10.1016\/j.actbio.2014.10.042_b0095","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1016\/j.biomaterials.2004.06.010","article-title":"The decrease of particle-induced osteolysis after a single dose of bisphosphonate","volume":"26","author":"Von Knoch","year":"2005","journal-title":"Biomaterials"},{"key":"10.1016\/j.actbio.2014.10.042_b0100","first-page":"34","article-title":"A systematic review assessing the effectiveness of alendronate in reducing periprosthetic bone loss after cementless primary THA","author":"Zeng","year":"2011","journal-title":"Orthopedics"},{"key":"10.1016\/j.actbio.2014.10.042_b0105","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1038\/35078107","article-title":"Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells","volume":"411","author":"Elbashir","year":"2001","journal-title":"Nature"},{"key":"10.1016\/j.actbio.2014.10.042_b0110","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/S0092-8674(01)00576-1","article-title":"On the role of RNA amplification in dsRNA-triggered gene silencing","volume":"107","author":"Sijen","year":"2001","journal-title":"Cell"},{"key":"10.1016\/j.actbio.2014.10.042_b0115","article-title":"Novel siRNA delivery strategy: a new \u201cstrand\u201d in CNS translational medicine?","author":"Gherardini","year":"2013","journal-title":"Cell Mol Life Sci CMLS"},{"key":"10.1016\/j.actbio.2014.10.042_b0120","first-page":"9","article-title":"RNA interference therapeutics for cancer: challenges and opportunities (review)","volume":"6","author":"Bora","year":"2012","journal-title":"Mol Med Rep"},{"key":"10.1016\/j.actbio.2014.10.042_b0125","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1007\/s11095-010-0099-5","article-title":"SiRNA Knock-down of RANK signaling to control osteoclast-mediated bone resorption","volume":"27","author":"Wang","year":"2010","journal-title":"Pharm Res"},{"key":"10.1016\/j.actbio.2014.10.042_b0130","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1186\/1471-2474-13-154","article-title":"Inhibition of osteoclastogenesis by RNA interference targeting RANK","volume":"13","author":"Ma","year":"2012","journal-title":"BMC Musculoskelet Disord"},{"key":"10.1016\/j.actbio.2014.10.042_b0135","doi-asserted-by":"crossref","first-page":"8540","DOI":"10.1016\/j.biomaterials.2012.07.039","article-title":"Selective local delivery of RANK siRNA to bone phagocytes using bone augmentation biomaterials","volume":"33","author":"Wang","year":"2012","journal-title":"Biomaterials"},{"key":"10.1016\/j.actbio.2014.10.042_b0140","doi-asserted-by":"crossref","first-page":"12177","DOI":"10.1073\/pnas.0501753102","article-title":"Efficient delivery of small interfering RNA to bone-metastatic tumors by using atelocollagen in vivo","volume":"102","author":"Takeshita","year":"2005","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.actbio.2014.10.042_b0145","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.1002\/art.21876","article-title":"Efficient new cationic liposome formulation for systemic delivery of small interfering RNA silencing tumor necrosis factor \u03b1 in experimental arthritis","volume":"54","author":"Khoury","year":"2006","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.actbio.2014.10.042_b0150","doi-asserted-by":"crossref","first-page":"2356","DOI":"10.1002\/art.23660","article-title":"Efficient suppression of murine arthritis by combined anticytokine small interfering RNA lipoplexes","volume":"58","author":"Khoury","year":"2008","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.actbio.2014.10.042_b0155","doi-asserted-by":"crossref","first-page":"528","DOI":"10.3109\/03008207.2012.702817","article-title":"Inhibitory effect of adenovirus-mediated siRNA-targeting BMPR-IB on UHMWPE-induced bone destruction in the murine air pouch model","volume":"53","author":"Wang","year":"2012","journal-title":"Connect Tissue Res"},{"key":"10.1016\/j.actbio.2014.10.042_b0160","doi-asserted-by":"crossref","first-page":"2452","DOI":"10.1002\/jbmr.455","article-title":"Formulated siRNAs targeting Rankl prevent osteolysis and enhance chemotherapeutic response in osteosarcoma models","volume":"26","author":"Rousseau","year":"2011","journal-title":"J Bone Miner Res Off J Am Soc Bone Miner Res"},{"key":"10.1016\/j.actbio.2014.10.042_b0165","doi-asserted-by":"crossref","DOI":"10.1007\/s10753-013-9636-9","article-title":"RNA Interference targeting p110\u03b2 reduces tumor necrosis factor-alpha production in cellular response to wear particles in vitro and osteolysis in vivo","author":"Huang","year":"2013","journal-title":"Inflammation"},{"key":"10.1016\/j.actbio.2014.10.042_b0170","doi-asserted-by":"crossref","first-page":"R100","DOI":"10.1186\/ar3381","article-title":"Oestrogen deficiency modulates particle-induced osteolysis","volume":"13","author":"Nich","year":"2011","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.actbio.2014.10.042_b0175","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1002\/jor.20987","article-title":"Decrease in particle-induced osteolysis in ovariectomized mice","volume":"28","author":"Nich","year":"2010","journal-title":"J Orthop Res"},{"key":"10.1016\/j.actbio.2014.10.042_b0180","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.bbagen.2009.01.005","article-title":"How to make siRNA lipoplexes efficient? Add a DNA cargo","volume":"1790","author":"Rhinn","year":"2009","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.actbio.2014.10.042_b0185","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1038\/cgt.2009.89","article-title":"Advantages of bioluminescence imaging to follow siRNA or chemotherapeutic treatments in osteosarcoma preclinical models","volume":"17","author":"Rousseau","year":"2010","journal-title":"Cancer Gene Ther"},{"key":"10.1016\/j.actbio.2014.10.042_b0190","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.canlet.2013.11.017","article-title":"NVP-BEZ235, a dual PI3K\/mTOR inhibitor, inhibits osteosarcoma cell proliferation and tumor development in vivo with an improved survival rate","volume":"344","author":"Gobin","year":"2014","journal-title":"Cancer Lett"},{"key":"10.1016\/j.actbio.2014.10.042_b0195","first-page":"n\/a","article-title":"BYL719, a new \u03b1-specific PI3K inhibitor: single administration and in combination with conventional chemotherapy for the treatment of osteosarcoma","author":"Gobin","year":"2014","journal-title":"Int J Cancer"},{"key":"10.1016\/j.actbio.2014.10.042_b0200","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms4511","article-title":"Selective inhibition of BET bromodomain epigenetic signalling interferes with the bone-associated tumour vicious cycle","volume":"5","author":"Lamoureux","year":"2014","journal-title":"Nat Commun"},{"key":"10.1016\/j.actbio.2014.10.042_b0205","doi-asserted-by":"crossref","unstructured":"Vandesompele J, De Preter K, Pattyn F, Poppe B, Van Roy N, De Paepe A, et al. Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol 2002;3:RESEARCH0034.","DOI":"10.1186\/gb-2002-3-7-research0034"},{"key":"10.1016\/j.actbio.2014.10.042_b0210","doi-asserted-by":"crossref","first-page":"2815","DOI":"10.1016\/j.actbio.2012.03.042","article-title":"Revision joint replacement, wear particles, and macrophage polarization","volume":"8","author":"Rao","year":"2012","journal-title":"Acta Biomater"},{"key":"10.1016\/j.actbio.2014.10.042_b0215","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1002\/stem.1040","article-title":"Induction of osteogenesis in mesenchymal stem cells by activated monocytes\/macrophages depends on oncostatin M signaling","volume":"30","author":"Guihard","year":"2012","journal-title":"Stem cells"},{"key":"10.1016\/j.actbio.2014.10.042_b0220","doi-asserted-by":"crossref","first-page":"e39871","DOI":"10.1371\/journal.pone.0039871","article-title":"Monocytes induce STAT3 activation in human mesenchymal stem cells to promote osteoblast formation","volume":"7","author":"Nicolaidou","year":"2012","journal-title":"PLoS ONE"},{"key":"10.1016\/j.actbio.2014.10.042_b0225","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1002\/jgm.1348","article-title":"TLR9-dependent systemic interferon-\u03b2 production by intravenous injection of plasmid DNA\/cationic liposome complex in mice","volume":"11","author":"Yoshida","year":"2009","journal-title":"J Gene Med"},{"key":"10.1016\/j.actbio.2014.10.042_b0230","doi-asserted-by":"crossref","unstructured":"Lonez C, Bessodes M, Scherman D, Vandenbranden M, Escriou V, Ruysschaert J-M. Cationic lipid nanocarriers activate Toll-like receptor 2 and NLRP3 inflammasome pathways. Nanomedicine Nanotechnol Biol Med n.d. doi:10.1016\/j.nano.2013.12.003.","DOI":"10.1016\/j.nano.2013.12.003"},{"key":"10.1016\/j.actbio.2014.10.042_b0235","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1038\/nm.2617","article-title":"A delivery system targeting bone formation surfaces to facilitate RNAi-based anabolic therapy","volume":"18","author":"Zhang","year":"2012","journal-title":"Nat Med"}],"container-title":["Acta Biomaterialia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1742706114005005?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1742706114005005?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,4,22]],"date-time":"2022-04-22T20:18:37Z","timestamp":1650658717000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1742706114005005"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,2]]},"references-count":47,"alternative-id":["S1742706114005005"],"URL":"https:\/\/doi.org\/10.1016\/j.actbio.2014.10.042","relation":{},"ISSN":["1742-7061"],"issn-type":[{"value":"1742-7061","type":"print"}],"subject":[],"published":{"date-parts":[[2015,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Inhibition of osteolysis and increase of bone formation after local administration of siRNA-targeting RANK in a polyethylene particle-induced osteolysis model","name":"articletitle","label":"Article Title"},{"value":"Acta Biomaterialia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.actbio.2014.10.042","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}